Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: RSV-F Vaccine Dose Ranging Study in Young Women [Phase 2]
The RSV-F vaccine dose-ranging study in young women (Phase 2) has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly [Phase 1]
A Phase 1 trial evaluating co-administration of an RSV-F vaccine with an influenza vaccine in elderly participants has completed.
-
CLINICAL_TRIALS withdrawal · 2013-10-28Clinical Trial Update: Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV) [Phase 1]
A Phase 1 safety study of GS-5806 for respiratory syncytial virus infection has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: MEDI-557 Adult Dosing [Phase 1]
Phase 1 trial update provides adult dosing information for MEDI-557 in Respiratory Syncytial Virus. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children [Phase 3]
Phase 3 trial results for Motavizumab (MEDI-524) in preventing serious RSV disease in high-risk children have been completed and results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-08-20Clinical Trial Update: Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age
A completed surveillance study of Respiratory Syncytial Virus (RSV) infections in children under 24 months, sponsored by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions [Phase 3]
Phase 3 trial evaluating Palivizumab for prevention of Respiratory Syncytial Virus infection in Japanese newborns, infants, and young childr…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 [Phase 1]
Phase 1 study evaluating pharmacokinetics, metabolism, and excretion of GS-5806 (Presatovir) in respiratory syncytial virus infection; study…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children [Phase 1, Phase 2]
This clinical trial update reports on safety, tolerability, and immunogenicity results for a second RSV prophylaxis season with Motavizumab …
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009
This completed clinical trial update describes the burden of respiratory syncytial virus infection in the United Kingdom from 1995 to 2009, …
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness [Phase 2]
A Phase 2 study update reports the results of RI-001 in immunosuppressed patients infected with Respiratory Syncytial Virus at risk for lowe…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Sofia RSV FIA Field Study
Quidel's Sofia RSV FIA field study for respiratory syncytial virus has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season [Phase 2]
A Phase 2 trial evaluated sequential administration of motavizumab and palivizumab during an RSV season in infants at risk for RSV infection…
-
CLINICAL_TRIALS research · 2012-11-14Clinical Trial Update: An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An observational study sponsored by MedImmune LLC to assess RSV-related respiratory events in premature infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA
Clinical trial update reporting the completion and posting of results for a study evaluating compliance with Synagis (palivizumab) in premat…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Collection and Testing of Respiratory Samples
A completed clinical trial assessing collection and testing of respiratory samples using the QIAGEN ResPlex II Advanced Panel and Artus Infl…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection
A completed trial evaluated the effectiveness of palivizumab immunoprophylaxis (Synagis) in high-risk preterm infants to prevent severe RSV …
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age [Phase 1]
Phase 1 safety and tolerability study of MEDI-534 in infants 6 to <24 months with viral respiratory infections, including RSV and parainflue…
-
FDA approval · 2012-04-04FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
The FDA approved a supplemental application for Synagis (palivizumab) filed by Swedish Orphan Biovitrum AB (publ). The action approves an up…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine [Phase 1]
This clinical trial update reports that a Phase 1 safety study of Novavax's RSV-F protein particle vaccine for Respiratory Syncytial Virus i…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children
Completed clinical trial sponsored by Abbott assessing the incidence of severe Respiratory Syncytial Virus infections in preterm Brazilian c…
-
FDA approval · 2011-11-16FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ribavirin from Aurobindo Pharma Limited, authorizing the generic ribavirin product.
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children [Phase 2, Phase 3]
Phase 2/3 clinical trial update on palivizumab for prevention of severe respiratory syncytial virus infection in high-risk Russian infants, …
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit [NA]
An update on a completed clinical trial evaluating a rapid diagnostic test for influenza and respiratory syncytial virus in a pediatric emer…
-
FDA approval · 2011-04-04FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
The FDA approved a supplemental application for Synagis (palivizumab) filed by Swedish Orphan Biovitrum AB (publ).